REN and malignant hypertension: In patients with MHT, the pretreatment plasma renin activity (PRA) is strongly correlated with the creatinine level and the concentration of LDH, which is a marker of microangiopathy [1] and likely reflects vascular damage mediated via the downstream effects on angiotensin II and aldosterone.